FdaApplication
NDA 018644
Identifiers
- fda_app_no: NDA018644
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1985-12-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WELLBUTRIN | BUPROPION HYDROCHLORIDE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| WELLBUTRIN | BUPROPION HYDROCHLORIDE | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| WELLBUTRIN | BUPROPION HYDROCHLORIDE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products